OUTCOMES OF DOSE ESCALATION AND DRUG LEVEL MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引：0
|
作者：
Scoville, Elizabeth A.
Izmaylov, Michelle L.
Bennett, Audrey
Evers, Lauren
Annis, Kim
Garrett, Ailish
Duley, Caroline
Adams, Dawn W.
Dalal, Robin L.
Beaulieu, Dawn
Schwartz, David A.
Horst, Sara N.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1862
引用
收藏
页码：S829 / S830
页数：2
相关论文
共 50 条
  • [31] Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease
    Lightner, Amy
    Raffals, Laura
    Mathis, Kellie
    Cima, Robert
    Tse, Chung Sang
    Pemberton, John
    Dozois, Eric
    Loftus, Edward V.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (02): : 185 - 190
  • [32] Proposed pathway for therapeutic drug monitoring and dose escalation of vedolizumab
    Nassar, Islam Osama
    Cheesbrough, Jonathan
    Quraishi, Mohammed Nabil
    Sharma, Naveen
    [J]. FRONTLINE GASTROENTEROLOGY, 2022, 13 (05) : 430 - 435
  • [33] IMPACT OF THERAPEUTIC DRUG MONITORING ON OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hussenbux, Arif
    Chopra, Tanya
    Stearns, Rebecca
    Ravindran, Rahul
    Patodi, Nishant
    De Silva, Aminda
    [J]. GUT, 2021, 70 : A100 - A100
  • [34] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [35] Characteristics of Patients Treated With Vedolizumab for Inflammatory Bowel Disease in the United States
    Mody, Reema
    Chastek, Benjamin
    Patel, Haridarshan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S779 - S780
  • [36] The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Abraham, Bincy P.
    Fan, Christopher
    Thurston, Theresa
    Moskow, Joshua
    Malaty, Hoda M.
    [J]. NUTRIENTS, 2023, 15 (22)
  • [37] Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab
    Zimmerman, Lori A.
    Zalieckas, Jill M.
    Shamberger, Robert C.
    Bousvaros, Athos
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (07) : 1330 - 1333
  • [38] Prior Authorization for Ustekinumab Dose Escalation Negatively Affects Outcomes in Patients With Inflammatory Bowel Disease
    Choi, David K.
    Puangampai, Archariya
    Rubin, David T.
    [J]. ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1279 - 1280
  • [39] Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease
    Lightner, Amy L.
    Tse, Chung Sang
    Potter, D. Dean, Jr.
    Moir, Christopher
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2018, 53 (09) : 1706 - 1709
  • [40] Comorbidity is associated with safety outcomes in vedolizumab- and ustekinumab-treated inflammatory bowel disease patients
    Asscher, V.
    Biemans, V.
    Pierik, M.
    Dijkstra, G.
    van der Meulen-de Jong, A.
    Lowenberg, M.
    van der Marel, S.
    de Boer, N.
    Bodelier, A.
    Jansen, J.
    West, R.
    Haans, J.
    van Dop, W.
    Weersma, R.
    Hoentjen, F.
    Maljaars, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S326 - S327
12345